Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis
Xia Liu, Runzhou Sun, Zhaozhen Li, Ruixin Xiao, Pengfei Lv, Xiangrong Sun, Mark A. Olson, Yanling Gong
Topics & Concepts
LuteolinGut floraFatty liverIntestinal permeabilityTLR4Barrier functionNonalcoholic fatty liver diseaseBiologyInternal medicinePharmacologyBiochemistryImmunologyFlavonoidReceptorMedicineDiseaseCell biologyAntioxidantLiver Disease Diagnosis and TreatmentGut microbiota and healthLipid metabolism and disorders